Research sheds light on low rates of genetic testing for cancer

Genetic testing for cancer can bring more knowledge to patients and their relatives, but not enough people get it done

10:27 AM

Author | Tessa Roy

cancer cell yellow blue
Jacob Dwyer, Justine Ross, Michigan Medicine

Not enough people are getting genetic testing for cancer, according to recent research.

Germline genetic testing, in which inherited DNA is sequenced, is recommended for patients diagnosed with cancer to enable genetically targeted treatment and identify additional relatives who can benefit from personalized cancer screening and prevention. Guidelines recommend this testing for people with cancers including breast, ovarian, pancreatic, colorectal, prostate and others.

Despite the knowledge this could bring to patients and their relatives, researchers found that only 6.8% out of a million patients underwent the testing within two years of receiving a diagnosis. The testing rates were lowest among Black, Hispanic, and Asian patients.

 

“We were surprised at the low rates of testing given the growing evidence for the benefits of results for  patients and their families,” said Steven Katz, M.D., M.P.H, Professor of Medicine and Health Management and Policy and leader of the Cancer Surveillance and Outcomes Research Team

“Genetic testing is increasingly important in treatment decision-making after diagnosis of cancer,” said Katz. “Testing the right patients at the right time can better personalize the treatment plan to maximize outcomes. Testing patients can be the gateway to identify hereditary cancer risk in families and offer prevention and early detection strategies that can save lives.” 

Testing has also become more accessible with the advancement of sequencing technology - the number of genes tested that are relevant to treatment and prevention has increased and costs for testing have declined.

“It’s not just about getting a test - it’s about integrating results into cancer management and prevention for patients and their families to save lives,” said Katz.

“We have shown that testing results often come too late to inform cancer management and too many patients with important test findings are left dangling on their own to communicate with their family about really complicated issues. We need to develop, deploy, and evaluate new strategies and tools to ensure that the rapid advances in genetic oncology are put into practice to improve health outcomes for patients and their families.”

Additional authors: Abrahamse, M.A., Allison Furgal, Ph.D., Rachel Tocco, Timothy P. Hofer, M.D., Steven J. Katz, M.D., M.P.H.

This research was supported by grant R01 CA225697 from the National Cancer Institute (NCI) (awarded to Stanford University) and grants P01 CA163233 and P30 CA046592 from the NCI (awarded to the University of Michigan). The collection of cancer incidence data in California was supported by the California Department of Public Health pursuant to California Health and Safety Code §103885 under cooperative agreement 5NU58DP006344 with the US Centers for Disease Control and Prevention (CDC) National Program of Cancer Registries, contract HHSN261201800032I with the NCI’s Surveillance, Epidemiology, and End Results (SEER) program (awarded to the University of California, San Francisco), contract HHSN261201800015I with the NCI’s SEER program (awarded to the University of Southern California), and contract HHSN261201800009I with the NCI’s SEER program (awarded to the Public Health Institute, Cancer Registry of Greater California). The collection of cancer incidence data in Georgia was supported by contract HHSN261201800003I and task order HHSN26100001 from the NCI and cooperative agreement 5NU58DP006352-03-00 from the CDC.

Paper cited: “Frequency of Germline Genetic Testing after Cancer Diagnosis,” Journal of American Medicine. DOI: 10.001/jama.2023.9526


More Articles About: Cancer (Oncology) Breast cancer Ovarian Cancer Pancreatic cancer Colorectal Cancer Prostate Cancer Cancer Diagnosis Cancer Testing Cancer Research Cancer Risk Factors
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories graphic drawing of woman falling and everything is pink and falling and floating with her like dna strands, cars, people, medicine, ID, blood vessels and cells
Health Lab
Why are more young people being diagnosed with cancer?
An article discusses causes of early-onset cancer and ways to reduce your risk.
Susan and Richard Rogel pose next to a grand piano. Rogel is wearing a polo shirt with a block M.
News Release
Rogel Cancer Center receives $50M gift to revolutionize pancreatic cancer care, research
New Rogel and Blondy Center for Pancreatic Cancer will bring together researchers and clinicians to drive forward new treatments and improve outcomes
doctors talking to eachother down a hallway
Health Lab
A collaborative approach to pancreatic cancer
The Rogel and Blondy Center for Pancreatic Cancer is a center of excellence in pancreatic cancer research, combining pioneering research with innovative clinical care and an array of clinical trials. Center co-director Marina Pasca di Magliano explains that the key to a robust research program and responsive care lies in collaboration.
jill martin close up blonde hair pink background and pink shirt
Health Lab
Jill Martin’s breast cancer journey
TODAY show contributor Jill Martin talks about breast cancer treatment and why she’s advocating for early detection and genetic screening.
Sewing Machine Cell Fabric Tangled
Health Lab
Research points to potential new treatment for aggressive prostate cancer subtype
In two separate papers, U-M researchers describe how a gene alteration drives prostate cancer and a potential degrader that stops it
white and light blue covid test drawing with words covid-19 test written with yellow background and blue
Health Lab
Big gaps seen in home medical test use by older adults
At-home medical diagnostic and screening tests for COVID-19 and many other conditions are now available; a new study shows disparities in use of these direct-to-consumer tests.